All About USP 467 Residual Solvent: Regulatory and Application Updates
Residual solvents are substances that remain in a drug product after the manufacturing process, originating from materials used or reactions occurring during production. Residual solvents pose potential health risks, so regulatory bodies like the ICH and the USP has set limits and testing requirements to ensure product safety.
Register for the webinar to know more about recent changes in USP 467, latest trends & applications in residual solvent analysis along with analytical workflow in order to get accurate & reproducible results
Presenter: Manu Grover (Business Development Manager – Pharma Markets, Agilent Technologies, Inc.)
Manu Grover holds a postgraduate degree in Pharmacy from Manipal Academy, India. He has more than 21 years of chromatography experience and has worked in pharmaceuticals to support IND, NDA, and ANDA filings incompanies such as Dr. Reddy's, Panacea Biotec, and Ozone Pharmaceuticals. During his professional journey, he has developed and validated analytical methods on HPLC, GC, particle sizing, DSC, pXRD, and LC/MS instruments, as well as successfully filing multiple analytical dossiers in U.S./EU markets. In his current role, he works closely with the Agilent sales team, regulators, and pharmaceutical scientists. He shares market updates, trends, and expertise related tothe Agilent portfolio of columns and supplies.
